Alx Oncology Holdings Inc. (ALXO)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 10
+0.03
+1.4493%
$
269.13M Market Cap
- P/E Ratio
- Div Yield
765,300 Volume
-3.52 Eps
$ 2.07
Previous Close 
Want to track ALXO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alx Oncology Holdings Inc. (ALXO) Statistics
Valuation metrics
Market Cap 269.13M
Enterprise value 255.52M
Trailing P/E (ttm) -1.27
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) -
Price/Book (mrq) 0.75
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.95
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 718.88K
Average volume (90 days) 939.01K
Price summary
52-Week low 0.44
52-Week high 2.66
Beta -
50-Day moving average 1.91
200-Day moving average 1.87
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.5%
Return on equity -1.24%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.64
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 7.21%
Book value per share (mrq) 2.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
